Deutsche Bank Maintains Buy on HCA Healthcare, Raises Price Target to $375
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering maintains a Buy rating on HCA Healthcare and raises the price target from $359 to $375.
June 28, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has reaffirmed its Buy rating on HCA Healthcare and increased the price target from $359 to $375, indicating a positive outlook for the stock.
The reaffirmation of the Buy rating and the increase in the price target by Deutsche Bank suggest a positive outlook for HCA Healthcare. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100